[R21] Developing breath biomarkers of S. aureus cystic fibrosis lung infections through the secondary analysis of IMPACT-Breath clinical study data
Ente: National Heart Lung and Blood Institute
Scadenza: 2027-04-30
Importo max: $233,854
Paese: US
Descrizione
Staphylococcus aureus is the most common cause of lung infections in the US cystic fibrosis (CF) population,
with nearly half (48.3%) of persons with CF testing positive for S. aureus in 2023. Testing for CF lung infections
heavily relies upon the collection of sputum, but as CF care improves throug
Settori: National Heart Lung and Blood Institute
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.